Role of circulating tumor DNA in early-stage triple-negative breast cancer: a systematic review and meta-analysis

Abstract Background Triple-negative breast cancer (TNBC) accounts for 15% of all breast cancers and carries a worse prognosis relative to other breast cancer subtypes. This systematic review and meta-analysis evaluated the prognostic value of circulating tumor DNA (ctDNA) in early-stage TNBC. Method...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Diana Zhang, Shayesteh Jahanfar, Judy B. Rabinowitz, Joshua Dower, Fei Song, Cherng-Horng Wu, Xiao Hu, Phillip Tracy, Mark Basik, Arielle Medford, Po-Han Lin, Chiun-Sheng Huang, Francois-Clement Bidard, Shufang Renault, Lori Pai, Mary Buss, Heather A. Parsons, Ilana Schlam
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	BMC 2025-03-01
Ráidu:	Breast Cancer Research
Fáttát:	Circulating tumor DNA Triple-negative breast cancer Prognosis Recurrence-free survival Disease free survival Overall survival
Liŋkkat:	https://doi.org/10.1186/s13058-025-01986-y
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!